{"version":"1.0","type":"link","title":"Immunological effects of amivantamab in EGFR or MET-expressing non-small cell lung cancer.","author_name":"Yoshichika R 외","author_url":"https://prs-insight.online/author/Yoshichika%20R","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/95359","thumbnail_width":1200,"thumbnail_height":630}